TY  - JOUR
AU  - Espinosa, Enrique
AU  - Soriano, Virtudes
AU  - Malvehy, Josep
AU  - Berrocal, Alfonso
AU  - Martínez de Prado, Purificación
AU  - Quindós, María
AU  - Soria, Ainara
AU  - Márquez-Rodas, Iván
AU  - Palacio, Isabel
AU  - Cerezuela, Pablo
AU  - López-Vivanco, Guillermo
AU  - Alonso, Lorenzo
AU  - Samaniego, Elia
AU  - Ballesteros, Ana
AU  - Puértolas, Teresa
AU  - Díaz-Beveridge, Rodrigo
AU  - de la Cruz-Merino, Luis
AU  - López Castro, Rafael
AU  - López López, Rafael
AU  - Stevinson, Kendall
AU  - Del Barrio, Patricia
AU  - Tornamira, Maria V
AU  - Guillém, Vicente
AU  - Martín-Algarra, Salvador
PY  - 2016
DO  - 10.1097/CMR.0000000000000254
UR  - http://hdl.handle.net/10668/9903
T2  - Melanoma research
AB  - Adjuvant interferon-α2b (IFN-α2b) has been studied extensively in clinical trials, but there have been few studies of real-world use. The aim of this study is to describe the IFN-α2b real-world patterns in patients with high-risk melanoma in Spain....
LA  - en
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Chemotherapy, Adjuvant
KW  - Cohort Studies
KW  - Female
KW  - Humans
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Male
KW  - Melanoma
KW  - Middle Aged
KW  - Retrospective Studies
KW  - Survival Analysis
KW  - Young Adult
TI  - Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma - Prima study.
TY  - research article
VL  - 26
ER  -